Heather C. Losey
- Molecular Biology top 5%
- Pharmacology top 1%
- Organic Chemistry top 5%
- Biotechnology top 2%
- Oncology
- Co-authors
- Christopher T. WalshA. M. MulichakR. Michael GaravitoCathryn A. Shaw-ReidGregory L. VerdineAlexander J. RuthenburgWei LüBrian K. Hubbard
- Topics
- Microbial Natural Products and Biosynthesis (10 papers)Cancer Immunotherapy and Biomarkers (7 papers)Carbohydrate Chemistry and Synthesis (6 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Clinical Oncology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Heather C. Losey
25 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 1.3k
- Pharmacology 798
- Organic Chemistry 542
- Biotechnology 247
- Oncology 151
Countries citing papers authored by Heather C. Losey
This map shows the geographic impact of Heather C. Losey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather C. Losey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather C. Losey more than expected).
Fields of papers citing papers by Heather C. Losey
This network shows the impact of papers produced by Heather C. Losey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather C. Losey. The network helps show where Heather C. Losey may publish in the future.
Co-authorship network of co-authors of Heather C. Losey
This figure shows the co-authorship network connecting the top 25 collaborators of Heather C. Losey. A scholar is included among the top collaborators of Heather C. Losey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather C. Losey. Heather C. Losey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 15 | |
| 4 | 2 | |
| 5 | 100 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 142 | |
| 9 | 49 | |
| 10 | 125 | |
| 11 | 17 | |
| 12 | 7 | |
| 13 | 128 | |
| 14 | 51 | |
| 15 | 163 | |
| 16 | 230 | |
| 17 | 142 | |
| 18 | 88 | |
| 19 | 92 | |
| 20 | 133 |
About Heather C. Losey
Heather C. Losey is a scholar working on Pharmacology, Biotechnology and Oncology, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Pharmacology (798 citations), Biotechnology (247 citations) and Molecular Biology (1.3k citations). Heather C. Losey has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Christopher T. Walsh, A. M. Mulichak, R. Michael Garavito, Cathryn A. Shaw-Reid, Gregory L. Verdine, Alexander J. Ruthenburg, Wei Lü, Brian K. Hubbard, Huawei Chen and Daniel Kahne. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.